Uploaded October 2019 | Updated September 2026, 16 hours ago
One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.
MJ Crom describes her experiences participating in a NIMH clinical trial, and how ketamine infusions changed her life and gave her a sense of purpose.
Dr. Carlos Zarate, a Senior Tenured Clinical Investigator at NIMH, describes his groundbreaking research on ketamine.
NIMH-funded ketamine research is enabling a deeper understanding of the biological causes of depression and other brain disorders. This knowledge could lead to the development of novel treatments in the future.
For more information, visit nimh.nih.gov/ketamineresearch.
One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.
MJ Crom describes her experiences participating in a NIMH clinical trial, and how ketamine infusions changed her life and gave her a sense of purpose.
Dr. Carlos Zarate, a Senior Tenured Clinical Investigator at NIMH, describes his groundbreaking research on ketamine.
NIMH-funded ketamine research is enabling a deeper understanding of the biological causes of depression and other brain disorders. This knowledge could lead to the development of novel treatments in the future.
For more information, visit nimh.nih.gov/ketamineresearch.
